Smile Holdings Inc.
Notice Regarding Full-Year Consolidated Earnings Forecasts for Fiscal Years Ending March 2027 and March 2028 (Growth Outlook Following the Complete Acquisition of WITH Holdings)
Full-year consolidated earnings forecast for the fiscal year ending March 2027 disclosed. Net sales of 25,500 million yen, operating profit of 1,000 million yen, ordinary profit of 450 million yen, net income attributable to owners of parent of 221 million yen, and earnings per share of 68.53 yen. For the fiscal year ending March 2028, net sales of 28,500 million yen, operating profit of 1,500 million yen, ordinary profit of 1,100 million yen, net income attributable to owners of parent of 700 million yen, and earnings per share of 217.06 yen.
Key Figures
- Net sales FY2027 forecast: 25,500 million yen
- Operating profit FY2027 forecast: 1,000 million yen
- Net income attributable to owners of parent FY2027 forecast: 221 million yen
- Net sales FY2028 forecast: 28,500 million yen
- Net income FY2028 forecast: 700 million yen
AI要約
Disclosure of earnings forecast and background
Pursuant to becoming a wholly owned subsidiary of WITH HD, the consolidated earnings forecast for the fiscal year ending March 2027 is disclosed for the first time. Large-scale M&A effects are expected to substantially boost operating profit, and for the fiscal year ending March 2028, the aim is a substantial improvement in profitability based on the full realization of business synergies and the elimination of one-time costs.
Financial impact and caveats
In the fiscal year ending March 2027, one-time M&A-related costs of about 400 million yen are included, resulting in net income attributable to owners of parent of 221 million yen, a slight year-over-year increase. It is stated that these one-time costs will have no impact from the following fiscal year. For the fiscal year ending March 2028, one-time costs are expected to be eliminated, leading to a substantial increase to 700 million yen in net income. Changes in figures may occur due to accounting treatments such as PPA.
Smile Holdings
Company overview · Stock price · Financial data · All IR
